175 related articles for article (PubMed ID: 26934317)
21. Prognostic factors for T1-2 colorectal cancer after radical resection: Lymph node distribution is a valuable predictor of its survival.
Huang X; Liu H; Liao X; Xiao Z; Huang Z; Li G
Asian J Surg; 2021 Jan; 44(1):241-246. PubMed ID: 32792113
[TBL] [Abstract][Full Text] [Related]
22. Integrated ratio of metastatic to examined lymph nodes and number of metastatic lymph nodes into the AJCC staging system for colon cancer.
Gao P; Song YX; Wang ZN; Xu YY; Tong LL; Zhu JL; Tang QC; Xu HM
PLoS One; 2012; 7(4):e35021. PubMed ID: 22529970
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma.
Kim SY; Nam SY; Choi SH; Cho KJ; Roh JL
Ann Surg Oncol; 2011 Aug; 18(8):2310-7. PubMed ID: 21336511
[TBL] [Abstract][Full Text] [Related]
24. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
25. Lymph node retrieval in colorectal cancer: determining factors and prognostic significance.
Betge J; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Int J Colorectal Dis; 2017 Jul; 32(7):991-998. PubMed ID: 28210855
[TBL] [Abstract][Full Text] [Related]
26. Lymph nodes, tumor deposits, and TNM: are we getting better?
Nagtegaal ID; Tot T; Jayne DG; McShane P; Nihlberg A; Marshall HC; Påhlman L; Brown JM; Guillou PJ; Quirke P
J Clin Oncol; 2011 Jun; 29(18):2487-92. PubMed ID: 21555695
[TBL] [Abstract][Full Text] [Related]
27. Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?
Tan Z; Ma G; Yang H; Zhang L; Rong T; Lin P
J Thorac Oncol; 2014 Aug; 9(8):1214-21. PubMed ID: 25157776
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.
Zhang BY; Yuan J; Cui ZS; Li ZW; Li XH; Lu YY
Am J Surg; 2014 Apr; 207(4):555-65. PubMed ID: 24124661
[TBL] [Abstract][Full Text] [Related]
29. A Modified Tumor-Node-Metastasis Classification for Stage III Colorectal Cancers Based on Treating Tumor Deposits as Positive Lymph Nodes.
Pei JP; Zhang CD; Fu X; Ba Y; Yue S; Zhao ZM; Dai DQ
Front Med (Lausanne); 2020; 7():571154. PubMed ID: 33178717
[No Abstract] [Full Text] [Related]
30. Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy.
Liu YL; Xu HT; Jiang SX; Yang YM; Cui BB
J Surg Oncol; 2014 Mar; 109(3):234-8. PubMed ID: 24449194
[TBL] [Abstract][Full Text] [Related]
31. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
Rosenberg R; Friederichs J; Schuster T; Gertler R; Maak M; Becker K; Grebner A; Ulm K; Höfler H; Nekarda H; Siewert JR
Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341
[TBL] [Abstract][Full Text] [Related]
33. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients.
Zhou ZG; Wu XJ; Li LR; Peng ZH; Ding PR; Wang RJ; Pan ZZ
Chin Med J (Engl); 2011 Jul; 124(14):2132-5. PubMed ID: 21933615
[TBL] [Abstract][Full Text] [Related]
34. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
35. The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer.
Kinoshita O; Kishimoto M; Murayama Y; Kuriu Y; Nakanishi M; Sakakura C; Otsuji E; Yanagisawa A
Int J Colorectal Dis; 2016 Feb; 31(2):283-90. PubMed ID: 26412250
[TBL] [Abstract][Full Text] [Related]
36. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer.
Liu H; Deng J; Zhang R; Hao X; Jiao X; Liang H
Int J Surg; 2013; 11(5):419-24. PubMed ID: 23541652
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of tumor deposits for long-term oncologic outcomes in patients with stage III colorectal cancer: a systematic review and meta-analysis.
Moon JY; Lee MR; Ha GW
Int J Colorectal Dis; 2022 Jan; 37(1):141-151. PubMed ID: 34595585
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the impact of lymph node resampling on colorectal cancer nodal stage.
Tran C; Howlett C; Driman DK
Histopathology; 2020 Dec; 77(6):974-983. PubMed ID: 32654207
[TBL] [Abstract][Full Text] [Related]
39. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
40. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
